Evaxion Biotech A/S(EVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EVAX Evaxion Biotech A/S

交易中 10-22 11:23:01 EDT

3.75

+0.04

+1.08%

最高3.75	最低3.57	成交量4.44万
今开3.73	昨收3.71	日振幅4.85%
总市值3,383万	流通市值2,385万	总股本902.15万
成交额16.14万	换手率0.70%	流通股本636.06万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EVAX","market":"US","secType":"STK","nameCN":"Evaxion Biotech A/S","latestPrice":3.75,"timestamp":1792682535450,"preClose":3.71,"halted":0,"volume":44417,"delay":0,"changeRate":0.010781671159029659,"floatShares":6360599,"shares":9021500,"eps":-1.088593,"marketStatus":"交易中","change":0.04,"latestTime":"10-22 11:23:01 EDT","open":3.73,"high":3.75,"low":3.57,"amount":161431.765403,"amplitude":0.048518,"askPrice":3.68,"askSize":100,"bidPrice":3.51,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.088593,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1792699200000},"marketStatusCode":2,"adr":0,"adrRate":50,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":3.71,"preHourTrading":{"tag":"盘前","latestPrice":3.9,"preClose":3.71,"latestTime":"08:56 EDT","volume":472,"amount":1799.414096,"timestamp":1792673793631,"change":0.19,"changeRate":0.051213,"amplitude":0.040431},"postHourTrading":{"tag":"盘后","latestPrice":3.71,"preClose":3.71,"latestTime":"19:57 EDT","volume":1006,"amount":3736.81,"timestamp":1792627056383,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.526021,"impliedVol":2.1042,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/EVAX/wiki","defaultTab":"wiki","newsList":[{"id":"1116759979","title":"Evaxion Biotech：Evx-05相关成本已纳入现有预算，不影响现金储备，资金续航能力延续至2027年下半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1116759979","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116759979?lang=zh_cn&edition=full","pubTime":"2026-08-17 20:10","pubTimestamp":1786968612,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S宣布，与Evx-05相关的各项成本均已纳入公司现有预算框架之内，并未对现金储备产生额外冲击。这家生物技术企业的资金续航能力依然稳固，可持续延伸至2027年下半年。在当前生物科技行业普遍面临融资压力的背景下，Evaxion的这一财务安排展现出审慎的资源管理能力。通过将新增项目成本内化于既有预算结构，公司有效规避了因额外开支而可能引发的资金链紧张风险，为其在研管线的持续推动奠定了坚实的财务基石。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138456362","title":"Evaxion Biotech A/S推出脑癌胶质母细胞瘤疫苗项目Evx-05，扩充癌症疫苗管线","url":"https://stock-news.laohu8.com/highlight/detail?id=1138456362","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138456362?lang=zh_cn&edition=full","pubTime":"2026-08-17 20:09","pubTimestamp":1786968549,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S宣布，其癌症疫苗管线再添新军——Evx-05，专攻脑癌中的胶质母细胞瘤。这一举措标志着公司在肿瘤免疫治疗领域迈出关键一步，进一步丰富了其创新疫苗产品线。Evx-05的研发聚焦于应对这种侵袭性极强的脑部恶性肿瘤，旨在通过激活患者自身免疫系统来精准攻击癌细胞。此举不仅展现了Evaxion在个性化癌症疫苗方面的持续深耕，也为其在神经肿瘤学这一高难度领域开辟了新赛道。随着Evx-05的加入，公司有望在未来临床开发中探索更多治疗可能性，为患者带来新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126261705","title":"Evaxion将于2026年5月7日发布业务进展及第一季度财务业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1126261705","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126261705?lang=zh_cn&edition=full","pubTime":"2026-05-04 20:04","pubTimestamp":1777896261,"startTime":"0","endTime":"0","summary":"临床阶段科技生物公司Evaxion Biotech A/S宣布，将于2026年5月7日（周四）纳斯达克资本市场开盘前，公布2026年第一季度财务报告及最新业务动态。公司高管团队将于同日欧洲中部时间14:30举行电话会议及网络直播，详细介绍业务进展与财务数据，并现场回应提问。Evaxion Biotech A/S是一家以前沿AI免疫学平台为核心的创新型科技生物企业。所有候选药物均聚焦于未满足的临床需求，彰显了通过创新靶向治疗方案改善患者生命的坚定承诺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","ARTY","BK4023","BK4555","BK4528","AGIX","AIPO","BK4543","03160","AIYY","TM","BK4587","BK4099","BK4551","BK4604","BK4588","BK4585","EVAX","AI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512164995","title":"Evaxion Biotech As盘中异动 早盘股价大涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512164995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512164995?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:48","pubTimestamp":1739893735,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时48分，Evaxion Biotech As股票出现波动，股价大幅上涨5.62%。截至发稿，该股报2.63美元/股，成交量12.8101万股，换手率2.04%，振幅6.83%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.75%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218234855a24abe46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218234855a24abe46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511918656","title":"Evaxion Biotech As盘中异动 急速下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511918656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511918656?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:51","pubTimestamp":1739544684,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时51分，Evaxion Biotech As股票出现异动，股价快速跳水5.17%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.42%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214225125a24605d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214225125a24605d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511525264","title":"Evaxion Biotech As盘中异动 快速上涨5.34%报2.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511525264?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:33","pubTimestamp":1739457213,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时33分，Evaxion Biotech As股票出现波动，股价快速拉升5.34%。截至发稿，该股报2.76美元/股，成交量2.5049万股，换手率0.40%，振幅0.00%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.17%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322333398842bf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322333398842bf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510808903","title":"Evaxion Biotech As盘中异动 股价大涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510808903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510808903?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:42","pubTimestamp":1739284974,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时42分，Evaxion Biotech As股票出现波动，股价快速拉升5.73%。Evaxion Biotech As股票所在的生物技术行业中，整体跌幅为1.34%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224254a241fd9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224254a241fd9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX","BK4139","OCEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510863263","title":"Evaxion Biotech As盘中异动 股价大跌6.59%报2.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510863263?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:31","pubTimestamp":1739197896,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分，Evaxion Biotech As股票出现波动，股价急速下跌6.59%。截至发稿，该股报2.41美元/股，成交量11.4004万股，换手率1.82%，振幅3.10%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.38%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223136a240a1d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223136a240a1d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509285977","title":"Evaxion Biotech As盘中异动 股价大跌5.09%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509285977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509285977?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:24","pubTimestamp":1738941840,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时24分，Evaxion Biotech As股票出现异动，股价急速跳水5.09%。截至发稿，该股报2.61美元/股，成交量23.4843万股，换手率3.75%，振幅6.55%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.15%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207232401987db78c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207232401987db78c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509277129","title":"Evaxion Biotech As盘中异动 早盘急速下挫5.69%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509277129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509277129?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:31","pubTimestamp":1738852292,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时31分，Evaxion Biotech As股票出现异动，股价急速下跌5.69%。截至发稿，该股报2.82美元/股，成交量11.5462万股，换手率1.84%，振幅0.67%。Evaxion Biotech As股票所在的生物技术行业中，整体跌幅为0.12%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223132abc4d44d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223132abc4d44d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509555469","title":"Lake Street：维持Evaxion Biotech(EVAX.US)评级，由买入调整至买入评级, 目标价由35.00美元调整至6.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509555469","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509555469?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:21","pubTimestamp":1738686095,"startTime":"0","endTime":"0","summary":"Lake Street：维持Evaxion Biotech(EVAX.US)评级，由买入调整至买入评级, 目标价由35.00美元调整至6.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/05002147950146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508576754","title":"Evaxion Biotech As盘中异动 早盘股价大涨55.42%报3.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508576754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508576754?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:32","pubTimestamp":1738679531,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时32分，Evaxion Biotech As股票出现异动，股价急速上涨55.42%。截至发稿，该股报3.73美元/股，成交量4275.67万股，换手率682.30%，振幅12.50%。Evaxion Biotech As股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Azitra Inc、Evaxion Biotech As、Invivyd, Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为883.46%、684.08%、185.92%，振幅较大的相关个股有Azitra Inc、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Omega Therapeutics, Inc.，振幅分别为25.82%、19.74%、18.97%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223212a23928e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223212a23928e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508914969","title":"Evaxion Biotech As盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508914969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508914969?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:36","pubTimestamp":1738593371,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时36分，Evaxion Biotech As股票出现波动，股价急速下跌5.09%。截至发稿，该股报2.33美元/股，成交量3.6203万股，换手率0.58%，振幅2.44%。Evaxion Biotech As股票所在的生物技术行业中，整体跌幅为0.35%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223611a2380ad7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223611a2380ad7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508114269","title":"HC Wainwright & Co.：重申Evaxion Biotech(EVAX.US)评级，由买入调整至买入评级, 目标价由14.00美元调整至14.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508114269","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508114269?lang=zh_cn&edition=full","pubTime":"2025-02-03 19:53","pubTimestamp":1738583623,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Evaxion Biotech(EVAX.US)评级，由买入调整至买入评级, 目标价由14.00美元调整至14.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/03195347940713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507296987","title":"Evaxion Biotech As盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507296987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507296987?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:32","pubTimestamp":1738333923,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时32分，Evaxion Biotech As股票出现异动，股价快速上涨5.26%。截至发稿，该股报2.60美元/股，成交量3.3885万股，换手率1.49%，振幅4.05%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.53%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223203a2354235&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223203a2354235&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2507364621","title":"Evaxion Biotech As盘中异动 早盘股价大跌24.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507364621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507364621?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:32","pubTimestamp":1738247533,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时32分，Evaxion Biotech As股票出现异动，股价快速下挫24.78%。截至发稿，该股报2.55美元/股，成交量38.0672万股，换手率16.78%，振幅1.77%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.28%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223213a2345531&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223213a2345531&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2507631637","title":"Evaxion Biotech As盘中异动 股价大涨5.05%报4.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507631637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507631637?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:30","pubTimestamp":1738161054,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时30分，Evaxion Biotech As股票出现波动，股价急速拉升5.05%。截至发稿，该股报4.59美元/股，成交量2.067万股，换手率1.76%，振幅6.41%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.00%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223054987609eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223054987609eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2506514845","title":"Evaxion Biotech As盘中异动 大幅下挫9.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506514845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506514845?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074674,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分，Evaxion Biotech As股票出现异动，股价大幅跳水9.67%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.01%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223114abbb6583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223114abbb6583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2506309167","title":"Evaxion Biotech As盘中异动 早盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506309167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506309167?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:30","pubTimestamp":1737988259,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时30分，Evaxion Biotech As股票出现波动，股价快速跳水5.14%。截至发稿，该股报5.72美元/股，成交量20.1767万股，换手率17.20%，振幅0.00%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.00%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012722305996123910&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012722305996123910&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2505662308","title":"Evaxion Biotech As盘中异动 急速上涨90.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505662308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505662308?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:31","pubTimestamp":1737729096,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时31分，Evaxion Biotech As股票出现异动，股价快速上涨90.66%。Evaxion Biotech As股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Pmgc Holdings Inc.、Evaxion Biotech As、Dogwood Therapeutics, Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Avenue Therapeutics, Inc.较为活跃，换手率分别为1997.72%、1136.10%、836.92%，振幅较大的相关个股有Pmgc Holdings Inc.、Conduit Pharmaceuticals Inc.、Bioxcel Therapeutics, Inc.，振幅分别为13.64%、11.80%、9.74%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223136a22e5a19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223136a22e5a19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evaxion.ai","stockEarnings":[{"period":"1week","weight":0.325},{"period":"1month","weight":0.1558},{"period":"3month","weight":0.2164},{"period":"6month","weight":-0.0794},{"period":"1year","weight":-0.4319},{"period":"ytd","weight":-0.2222}],"compareEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.0005},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0829},{"period":"1year","weight":0.1516},{"period":"ytd","weight":0.1337}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Evaxion A/S根据丹麦王国的法律于2008年8月11日成立。该公司是一家临床阶段公司，利用其专有的人工智能或AI、技术、工程专业知识和药物开发知识来模拟人体免疫系统并生成预测模型，以识别和开发用于治疗各种癌症、细菌性疾病和病毒感染的新免疫疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.312391},{"month":2,"riseRate":0,"avgChangeRate":-0.075072},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.067423},{"month":4,"riseRate":0.666667,"avgChangeRate":0.093874},{"month":5,"riseRate":0.333333,"avgChangeRate":0.041103},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.074845},{"month":7,"riseRate":0.333333,"avgChangeRate":0.03566},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.030304},{"month":9,"riseRate":1,"avgChangeRate":0.179864},{"month":10,"riseRate":0.5,"avgChangeRate":0.106904},{"month":11,"riseRate":0.2,"avgChangeRate":-0.236379},{"month":12,"riseRate":0,"avgChangeRate":-0.21322}],"exchange":"NASDAQ","name":"Evaxion Biotech A/S","nameEN":"Evaxion Biotech A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evaxion Biotech A/S(EVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Evaxion Biotech A/S(EVAX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Evaxion Biotech A/S,EVAX,Evaxion Biotech A/S股票,Evaxion Biotech A/S股票老虎,Evaxion Biotech A/S股票老虎国际,Evaxion Biotech A/S行情,Evaxion Biotech A/S股票行情,Evaxion Biotech A/S股价,Evaxion Biotech A/S股市,Evaxion Biotech A/S股票价格,Evaxion Biotech A/S股票交易,Evaxion Biotech A/S股票购买,Evaxion Biotech A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evaxion Biotech A/S(EVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Evaxion Biotech A/S(EVAX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}